89bio stock falls following public offering announcement
Shares of 89bio, Inc. (NASDAQ:ETNB) tumbled 6% after the company announced its plans for an underwritten public offering of common stock and pre-funded warrants. The clinical-stage biopharmaceutical company,
BriaCell Therapeutics Announces Pricing of Public Offering
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Smithfield Foods Announces Launch of Initial Public Offering
Smithfield Foods, Inc., announced that it has “commenced the roadshow” for an underwritten initial public offering of 34,800,000 shares of its common stock.
BriaCell announces public offering of common shares
PHILADELPHIA and VANCOUVER, British Columbia - BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in immunotherapies for cancer care, announced today its plans to conduct a best-efforts public offering of common shares.
GH Research Announces Proposed Public Offering
GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced the commencement of an underwritten public offering in the United States of $150 million of ordinary shares.
Butterfly Network Announces Pricing of $75.6 million Public Offering of Common Stock
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ult
Decent Holding Inc. Announces Pricing of Initial Public Offering
Decent Holding Inc. (the “Company”), an established wastewater treatment services provider in China, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.
Annovis Bio announces pricing of $21M offering of stock, warrants
Annovis Bio (ANVS) announced the pricing of an underwritten public offering of 5.25M shares of common stock and warrants to purchase 5,250,000
Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
(GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD),
Investopedia2mon
Initial Public Offerings (IPOs)
Learn More What Are the Advantages and Disadvantages of a Company Going Public? How are IPOs priced? IPOs technically have two prices, their offering price, and opening price. The offering ...
Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
Vertical Aerospace (Vertical) (NYSE: EVTL) ("Vertical" or the "Company"), a global aerospace and technology company that is ...
Times Union10d
Initial public offerings scheduled to debut next week
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Smithfield Foods - Smithfield ...
Business Wire3d
Atlas Energy Solutions Announces Pricing of Upsized Underwritten Public Offering of Common Stock
Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today announced the pricing of an upsized underwritten public offering (the “Offer ...
When Did Facebook (Meta) Go Public?
Facebook (Meta) had one of the largest and most anticipated IPOs in history on May 18, 2012, but it failed to meet expectations. A NASDAQ glitch cost investors.